Expression of matrix metalloproteinases in human breast cancer tissues

Disease Markers

Volumn 34, Issue 6, 2013, Pages 395-405

  Benson, Chellakkan Selvanesan ^a   Babu, Somasundaram Dinesh ^a   Radhakrishna, Selvi ^b   Selvamurugan, Nagarajan ^c   Sankar, Bhaskaran Ravi ^a  

^a UNIVERSITY OF MADRAS   (India)

^b Chennai Transplant Centre   (India)

^c SRM INSTITUTE OF SCIENCE AND TECHNOLOGY   (India)

Author keywords

breast cancer; cancer grade; diagnostic marker; matrix degradation; Matrix metalloproteinase

Indexed keywords

COLLAGENASE 3; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; MACROPHAGE ELASTASE; MATRILYSIN; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 15; MATRIX METALLOPROTEINASE 16; MATRIX METALLOPROTEINASE 17; MATRIX METALLOPROTEINASE 19; MATRIX METALLOPROTEINASE 20; MATRIX METALLOPROTEINASE 21; MATRIX METALLOPROTEINASE 23; MATRIX METALLOPROTEINASE 24; MATRIX METALLOPROTEINASE 25; MATRIX METALLOPROTEINASE 26; MATRIX METALLOPROTEINASE 27; MATRIX METALLOPROTEINASE 28; NEUTROPHIL COLLAGENASE; PROGESTERONE RECEPTOR; STROMELYSIN; STROMELYSIN 2; STROMELYSIN 3; UNCLASSIFIED DRUG;

ADULT; AGED; ANGIOGENESIS; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER SIZE; CANCER SURGERY; CANCER TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; TUMOR INVASION; UPREGULATION;

EID: 84878831181     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.3233/DMA-130986     Document Type: Article

References (47)

1. Egeblad M,Werb Z (2002) New functions for the matrix metalloproteinases in cancer progression. Nature Reviews Cancer 2(3): 161-174.
2. Nagase H, Visse R, Murphy G (2006) Structure and function of matrix metalloproteinases and TIMPs. Cardiovascular Research 69(3): 562-573.
3. Sternlicht MD,Werb Z (2001) How matrix metalloproteinases regulate cell behavior. Annual Review of Cell and Developmental Biology 17: 463-516.
4. Kohrmann A, Kammerer U, Kapp M, Dietl J, Anacker J (2009) Expression of matrix metalloproteinases (MMPs) in primary human breast cancer and breast cancer cell lines: New findings and review of the literature. BMC Cancer 9: 188.
5. Mark D Sternlicht GB (2000) Matrix metalloproteinases as emerging targets in anticancer therapy: Status and prospects. Emerging Therapeutic Targets 4: 609-633.
6. Eiseler T, Doppler H, Yan IK, Goodison S, Storz P (2009) Protein kinase D1 regulates matrix metalloproteinase expression and inhibits breast cancer cell invasion. Breast Cancer Research: BCR 11(1): R13.
7. Basset P, Bellocq JP, Wolf C, Stoll I, Hutin P, Limacher JM, Podhajcer OL, Chenard MP, Rio MC, Chambon P (1990) A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature 348(6303): 699-704.
8. Pivetta E, Scapolan M, Pecolo M, Wassermann B, Abu-Rumeileh I, Balestreri L, Borsatti E, Tripodo C, Colombatti A, Spessotto P (2011) MMP-13 stimulates osteoclast differentiation and activation in tumour breast bone metastases. Breast Cancer Research: BCR 13(5): R105.
9. Lochter A, Galosy S, Muschler J, Freedman N, Werb Z, Bissell MJ (1997) Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular alterations that leads to stable epithelial-to-mesenchymal conversion and a premalignant phenotype in mammary epithelial cells. The Journal of Cell Biology 139(7): 1861-1872.
10. Keshgegian AA, Cnaan A (1996) Estrogen receptor-negative, progesterone receptor-positive breast carcinoma: Poor clinical outcome. Archives of Pathology and Laboratory Medicine 120(10): 970-973.
11. Surowiak P, Dziegiel P, Zabel M, Matkowski R, Kornafel J (2001) Analysis of estrogen receptor (ER) and estrogendependent pS2 protein expression in cells of mammary ductal carcinoma. Folia histochemica et cytobiologica/Polish Academy of Sciences, Polish Histochemical and Cytochemical Society 39(2): 141-142.
12. Chabottaux V, Sounni NE, Pennington CJ, English WR, van den Brule F, Blacher S, Gilles C,Munaut C, Maquoi E, Lopez-Otin C, Murphy G, Edwards DR, Foidart JM, Noel A (2006) Membrane-type 4 matrix metalloproteinase promotes breast cancer growth and metastases. Cancer Research 66(10): 5165-5172.
13. Balduyck M, Zerimech F, Gouyer V, Lemaire R, Hemon B, Grard G, Thiebaut C, Lemaire V, Dacquembronne E, Duhem T, Lebrun A, Dejonghe MJ, Huet G (2000) Specific expression of matrix metalloproteinases 1, 3, 9 and 13 associated with invasiveness of breast cancer cells in vitro. Clinical and Experimental Metastasis 18(2): 171-178.
14. Delassus GS, Cho H, Park J, Eliceiri GL (2008) New pathway links from cancer-progression determinants to gene expression of matrix metalloproteinases in breast cancer cells. Journal of Cellular Physiology 217(3): 739-744.
15. Hegedus L, Cho H, Xie X, Eliceiri GL (2008) Additional MDA-MB-231 breast cancer cell matrix metalloproteinases promote invasiveness. Journal of Cellular Physiology 216(2): 480-485.
16. Lynch CC, Vargo-Gogola T, Matrisian LM, Fingleton B (2010) Cleavage of E-Cadherin by Matrix Metalloproteinase-7 Promotes Cellular Proliferation in Nontransformed Cell Lines via Activation of RhoA. Journal of Oncology 2010: 530745.
17. Meric F, Hung MC, Hortobagyi GN, Hunt KK (2002) HER2/neu in the management of invasive breast cancer. Journal of the American College of Surgeons 194(4): 488-501.
18. Roy R, Yang J, Moses MA (2009) Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer. Journal of clinical oncology: Official Journal of the American Society of Clinical Oncology 27(31): 5287-5297.
19. Wu ZS,Wu Q, Yang JH,Wang HQ, Ding XD, Yang F, Xu XC (2008) Prognostic significance of MMP-9 and TIMP-1 serum and tissue expression in breast cancer. International Journal of Cancer Journal International du Cancer 122(9): 2050-2056.
20. Fernandez CA, Yan L, Louis G, Yang J, Kutok JL,Moses MA (2005) The matrix metalloproteinase-9/neutrophil gelatinaseassociated lipocalin complex plays a role in breast tumor growth and is present in the urine of breast cancer patients. Clinical cancer research: An official Journal of the American Association for Cancer Research 11(15): 5390-5395.
21. Mannello F, Malatesta M, Sebastiani M, Battistelli S, Gazzanelli G (1999) Molecular forms and ultrastructural localization of prostate-specific antigen in nipple aspirate fluids. Clinical Chemistry 45(12): 2263-2266.
22. La Rocca G, Pucci-Minafra I, Marrazzo A, Taormina P, Minafra S (2004) Zymographic detection and clinical correlations of MMP-2 and MMP-9 in breast cancer sera. British Journal of Cancer 90(7): 1414-1421.
23. Yokoyama M, Ochi K, Ichimura M, Mizushima T, Shinji T, Koide N, Tsurumi T, Hasuoka H, Harada M (2002) Matrix metalloproteinase-2 in pancreatic juice for diagnosis of pancreatic cancer. Pancreas 24(4): 344-347.
24. Roy R, Louis G, Loughlin KR, Wiederschain D, Kilroy SM, Lamb CC, Zurakowski D, Moses MA (2008) Tumor-specific urinary matrix metalloproteinase fingerprinting: Identification of high molecular weight urinary matrix metalloproteinase species. Clinical cancer research: An official journal of the American Association for Cancer Research 14(20): 6610-6617.
25. Koc M, Ediger D, Budak F, Karadag M, Oral HB, Uzaslan E, Ege E, Gozu RO (2006) Matrix metalloproteinase-9 (MMP-9) elevated in serum but not in bronchial lavage fluid in patients with lung cancer. Tumori 92(2): 149-154.
26. Hilska M, Roberts PJ, Collan YU, Laine VJ, Kossi J, Hirsimaki P, Rahkonen O, Laato M (2007) Prognostic significance of matrix metalloproteinases-1, -2, -7 and -13 and tissue inhibitors of metalloproteinases-1, -2, -3 and -4 in colorectal cancer. International Journal of Cancer Journal International du Cancer 121(4): 714-723.
27. Lengyel E, Schmalfeldt B, Konik E, Spathe K, Harting K, Fenn A, Berger U, Fridman R, Schmitt M, Prechtel D, Kuhn W (2001) Expression of latent matrix metalloproteinase 9 (MMP-9) predicts survival in advanced ovarian cancer. Gynecologic Oncology 82(2): 291-298.
28. Morgia G, Falsaperla M, Malaponte G, Madonia M, Indelicato M, Travali S, Mazzarino MC (2005) Matrix metalloproteinases as diagnostic (MMP-13) and prognostic (MMP-2, MMP-9) markers of prostate cancer. Urological Research 33(1): 44-50.
29. Choe G, Park JK, Jouben-Steele L, Kremen TJ, Liau LM, Vinters HV, Cloughesy TF, Mischel PS (2002) Active matrix metalloproteinase 9 expression is associated with primary glioblastoma subtype. Clinical cancer research: An official journal of the American Association for Cancer Research 8(9): 2894-2901.
30. Thiery JP (2002) Epithelial-mesenchymal transitions in tumour progression. Nature Reviews Cancer 2(6): 442-454.
31. Bergers G, Brekken R, McMahon G, Vu TH, Itoh T, Tamaki K, Tanzawa K, Thorpe P, Itohara S, Werb Z, Hanahan D (2000) Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nature Cell Biology 2(10): 737-744.
32. Mannello F (2011) What does matrix metalloproteinase-1 expression in patients with breast cancer really tell us? BMC Medicine 9: 95.
33. Luukkaa M, Vihinen P, Kronqvist P, Vahlberg T, Pyrhonen S, Kahari VM, Grenman R (2006) Association between high collagenase-3 expression levels and poor prognosis in patients with head and neck cancer. Head and Neck 28(3): 225-234.
34. Zhang B, Cao X, Liu Y, CaoW, Zhang F, Zhang S, Li H, Ning L, Fu L, Niu Y, Niu R, Sun B, Hao X (2008) Tumor-derived matrix metalloproteinase-13 (MMP-13) correlates with poor prognoses of invasive breast cancer. BMC Cancer 8: 83.
35. Kwok S, Rittling SR, Partridge NC, Benson CS, Thiyagaraj M, Srinivasan N, Selvamurugan N (2009) Transforming growth factor-beta1 regulation of ATF-3 and identification of ATF-3 target genes in breast cancer cells. Journal of Cellular Biochemistry 108(2): 408-414.
36. Selvamurugan N, Kwok S, Partridge NC (2004) Smad3 interacts with JunB and Cbfa1/Runx2 for transforming growth factor-beta1-stimulated collagenase-3 expression in human breast cancer cells. The Journal of Biological Chemistry 279(26): 27764-27773.
37. Selvamurugan N, Kwok S, Alliston T, Reiss M, Partridge NC (2004) Transforming growth factor-beta 1 regulation of collagenase-3 expression in osteoblastic cells by cross-talk between the Smad and MAPK signaling pathways and their components, Smad2 and Runx2. The Journal of Biological Chemistry 279(18): 19327-19334.
38. Pratap J, Javed A, Languino LR, van Wijnen AJ, Stein JL, Stein GS, Lian JB (2005) The Runx2 osteogenic transcription factor regulates matrix metalloproteinase 9 in bone metastatic cancer cells and controls cell invasion. Molecular and Cellular Biology 25(19): 8581-8591.
39. Yu Q, Stamenkovic I (2004) Transforming growth factorbeta facilitates breast carcinoma metastasis by promoting tumor cell survival. Clinical and Experimental Metastasis 21(3): 235-242.
40. McCawley LJ, Crawford HC, King LE, Jr., Mudgett J, Matrisian LM (2004) A protective role for matrix metalloproteinase-3 in squamous cell carcinoma. Cancer Research 64(19): 6965-6972.
41. Deraz EM, Kudo Y, Yoshida M, Obayashi M, Tsunematsu T, Tani H, Siriwardena SB, Keikhaee MR, Qi G, Iizuka S, Ogawa I, Campisi G, Lo Muzio L, Abiko Y, Kikuchi A, Takata T (2011) MMP-10/stromelysin-2 promotes invasion of head and neck cancer. PloS One 6(10): e25438.
42. Strong AL, Semon JA, Strong TA, Santoke TT, Zhang S, McFerrin HE, Gimble JM, Bunnell BA (2012) Obesityassociated dysregulation of calpastatin and MMP-15 in adipose-derived stromal cells results in their enhanced invasion. Stem Cells 30(12): 2774-2783.
43. Luo YP, Zhong M, Wang LP, Sun GQ, Li J (2009) Inhibitory effects of RNA interference on MMP-24 expression and invasiveness of ovarian cancer SKOV(3) cells. Journal of Southern Medical University 29(4): 781-784.
44. Sun Q,Weber CR, Sohail A, Bernardo MM, Toth M, Zhao H, Turner JR, Fridman R (2007) MMP25 (MT6-MMP) is highly expressed in human colon cancer, promotes tumor growth, and exhibits unique biochemical properties. The Journal of Biological Chemistry 282(30): 21998-22010.
45. Shapiro SD, Kobayashi DK, Ley TJ (1993) Cloning and characterization of a unique elastolytic metalloproteinase produced by human alveolar macrophages. The Journal of Biological Chemistry 268(32): 23824-23829.
46. Sena P, Mariani F, Marzona L, Benincasa M, Ponz de Leon M, Palumbo C, Roncucci L (2012) Matrix metalloproteinases 15 and 19 are stromal regulators of colorectal cancer development from the early stages. International Journal of Oncology 41(1): 260-266.
47. Impola U, Toriseva M, Suomela S, Jeskanen L, Hieta N, Jahkola T, Grenman R, Kahari VM, Saarialho-Kere U (2003) Matrix metalloproteinase-19 is expressed by proliferating epithelium but disappears with neoplastic dedifferentiation. International Journal of Cancer Journal International du Cancer 103(6): 709-716.